Myofascial Pain SyndromeNCT05320601
Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Myofascial Pain Syndrome
A study testing Repetitive Peripheral Magnetic Stimulation and Dry needling in people with Myofascial Pain Syndrome, run by Mahidol University at 1 site in Thailand.
Trial summary
Compare efficiency between repetitive peripheral magnetic stimulation and dry needling in patient with upper trapezius myofascial pain syndrome. Read more about this study
- Who is it for?
- Ages 20 to 45 years
- Conditions the study is for
- Myofascial Pain Syndrome
- What is being tested?
- Repetitive Peripheral Magnetic Stimulation and Dry needling
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 siteThailand
- Study dates
- 11 Apr 2022to 1 Jul 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Patients with myofascial pain syndrome at unilateral upper trapezius muscle and had pain score (Visual analog scale) at least 4
Who cannot join
- Patients with signs and/or symptoms of neurological deficit
- Patients with history of cervical hernia, cervical radiculopathy, cervical myelopathy, fibromyalgia, whiplash spondylosis and cervical spinal stenosis.
- Patients who received physical therapy/injection/surgery at neck or pain area in last 6 months.
- Patients with abnormal coagulopathy and/or currently use anticoagulant medicine.
- Patients with cardiac device.
- Patients with history of aneurysm clip procedure, stent-coils procedure or cochlear implant surgery.
- Pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Patient With Upper Trapezius Myofascial Pain Syndrome
Compare efficiency between repetitive peripheral magnetic stimulation and dry needling in patient with upper trapezius myofascial pain syndrome.
- Conditions
- Myofascial Pain Syndrome
- Being tested
- Repetitive Peripheral Magnetic Stimulation, Dry needling
- Medical subject headings
- Myofascial Pain Syndromes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Repetitive Peripheral Magnetic StimulationDevice
Repetitive Peripheral Magnetic Stimulation at trigger point of upper trapezius muscle
Dry needlingProcedure or surgery
Dry needling at trigger point of upper trapezius muscle
| Study group | Role | What they receive |
|---|---|---|
| Repetitive Peripheral Magnetic Stimulation | Experimental | Repetitive Peripheral Magnetic Stimulation 1 session Receives: Device: Repetitive Peripheral Magnetic Stimulation |
| Dry Needling | Experimental | Dry Needling 1 session Receives: Procedure: Dry needling |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change of Visual analog scale
Pain measurement Score from 0-10, 0 means no pain and 10 means maximum pain. Higher scores mean worse outcome.
Measured: Change from baseline Visual analog scale at immediately after intervention, Change from Baseline visual analog scale at 1 week and Change from baseline Visual analog scale at 4 weeks
Secondary outcomes (1)
Neck disability index
Disability secondary to neck pain Score from 0-50, 0 means no disability and 50 means complete disability. Higher scores mean worse outcome.
Measured: Change from baseline Neck disability index at immediately after intervention, Change from Baseline Neck disability index at 1 week and Change from baseline Neck disability index at 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2022
- Study start11 Apr 2022
- Primary completion1 May 2022
- Study completion1 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myofascial Pain SyndromeStudies of the same condition, open and under way.
- More trials run by Mahidol UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Care provider, Outcomes assessor
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mahidol University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Apiphan Iamchaimongkol, MD, Mahidol University
- Investigators
- Apiphan Iamchaimongkol, M.D., Study director, Ramathibodi Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05320601
- Sponsor's protocol ID
- AIamchaimongkol
- Status last verified
- Jul 2022
- First submitted
- 25 Mar 2022
- Last updated
- 5 Jul 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jul 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Patient With Upper Trapezius Myofascial Pain Syndrome
- ClinicalTrials.gov ID
- NCT05320601
- Acronym / sponsor ID
- AIamchaimongkol
- Conditions
- Myofascial Pain Syndrome
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 32 participants (actual)
- Lead sponsor
- Mahidol UniversityUniversity, hospital or other
- Study start
- 11 Apr 2022 (actual)
- Primary completion
- 1 May 2022 (actual)
- Study completion
- 1 Jul 2022 (actual)
- First posted
- 11 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Compare efficiency between repetitive peripheral magnetic stimulation and dry needling in patient with upper trapezius myofascial pain syndrome.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Repetitive Peripheral Magnetic Stimulation | Experimental | Device: Repetitive Peripheral Magnetic StimulationRepetitive Peripheral Magnetic Stimulation 1 session |
| Dry Needling | Experimental | Procedure: Dry needlingDry Needling 1 session |
Who may qualify
- Ages
- 20 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Patients with myofascial pain syndrome at unilateral upper trapezius muscle and had pain score (Visual analog scale) at least 4
Key exclusion criteria (7 listed)
- Patients with signs and/or symptoms of neurological deficit
- Patients with history of cervical hernia, cervical radiculopathy, cervical myelopathy, fibromyalgia, whiplash spondylosis and cervical spinal stenosis.
- Patients who received physical therapy/injection/surgery at neck or pain area in last 6 months.
- Patients with abnormal coagulopathy and/or currently use anticoagulant medicine.
- Patients with cardiac device.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Repetitive Peripheral Magnetic StimulationRepetitive Peripheral Magnetic Stimulation at trigger point of upper trapezius muscle | Device | Repetitive Peripheral Magnetic Stimulation |
| Dry needlingDry needling at trigger point of upper trapezius muscle | Procedure or surgery | Dry Needling |
Primary outcome
Change of Visual analog scale
Time frame: Change from baseline Visual analog scale at immediately after intervention, Change from Baseline visual analog scale at 1 week and Change from baseline Visual analog scale at 4 weeks
Pain measurement Score from 0-10, 0 means no pain and 10 means maximum pain. Higher scores mean worse outcome.
1 secondary outcome
Neck disability index
Time frame: Change from baseline Neck disability index at immediately after intervention, Change from Baseline Neck disability index at 1 week and Change from baseline Neck disability index at 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jul 2022.
- The effect of repetitive magnetic stimulation on localized musculoskeletal painLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Myofascial Pain Syndrome
Not yet recruiting
Effects of IASTM, Deep Friction Massage, and Sham Instrument-Assisted Soft Tissue Mobilization on Electromyographical Activation, Pain and Function in Non-Specific Low Back Pain
Low Back Pain, Trigger Point Pain, Myofascial
Not yet recruitingObservational study
Agreement Between CSI and IASP Pain Classification in Chronic Cervical Myofascial Pain
Myofascial Pain Syndrome - Neck
Active, not recruiting
Comparing Instrument-Assisted Soft Tissue Mobilization and Muscle Energy Technique for Myofascial Pain Syndrome in Women
Myofascial Pain Syndrome
Recruiting
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
Myofacial Pain, Myofacial Pain Syndrome
Not yet recruiting
Focused Versus Multi-Target Trigger Point Injection for Chronic Myofascial Neck Pain
Myofacial Pain Syndrome, Chronic Neck Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Apiphan Iamchaimongkol, M.D. study director
Ramathibodi Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Repetitive Peripheral Magnetic Stimulation and Dry needling in people with Myofascial Pain Syndrome, run by Mahidol University at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change of Visual analog scale (time frame: Change from baseline Visual analog scale at immediately after intervention, Change from Baseline visual analog scale at 1 week and Change from baseline Visual analog scale at 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2022; AzTrials last refreshed its copy on 7 Nov 2026.